Methods and compositions relating to muscle selective calcineurin interacting protein (mcip)
CA 2415967 A1 · Owner: Rothermel, Beverly · Inventors: Williams, Sanders R.; Rothermel, Beverly
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the polypeptides known as muscle calcineurin interacting proteins (MCIPs). These molecules binding to calcineurin and in , so doing, modulate its functions, which includes phosphate removal as part of a pathway coupling Ca2+ to cellular responses in muscle. MCIPs form a physical complex with the catalytic subunit of calcineurin and increased levels of , MCIPs correspond to a reduced ability of calcineurin to stimulate transcription of certain target genes. Methods to exploit these observations are provided and include screening for modulators of MCIP expression and binding to calcineurin, methods of diagnosis of MCIP defects and methods for , treating …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 6, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 6, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 6, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.